Thanks. If I recall correctly from an investor webinar, the CEO mentioned Pfizer tried a spray delivery method in 2000s but it didn't go ahead due to challenges. Whilst LTP has been successful with Vardenafil in developing the spray delivery method that seems to be unique to Vardenafil due its properties presumably different from other ED pills. In any case, the proposal is that Spontan is superior to all ED pills, and where others have tried and failed with changing the delivery method, Spontan ought to be enough to successfully disrupt the market. According to the CEO he is only aware of the inventor of Spontan having achieved this.
Thanks. If I recall correctly from an investor webinar, the CEO...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 407 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |